[Form 4] Cisco Systems, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Rapid Micro Biosystems, Inc. (RPID) filed a LIVE Form 144 indicating that shareholder Robert G. Spignesi intends to sell up to 11,881 Class A shares through Fidelity Brokerage Services on or about 14 July 2025. At the disclosed aggregate market value of $39,480.56, the transaction equates to roughly 0.03 % of the company’s 39,332,172 shares outstanding, signalling minimal dilution.

The shares were acquired on 11 July 2025 via restricted-stock vesting and are therefore compensation related. The filing also details four prior sales by the same holder between 8-11 July 2025 totalling 45,562 shares for gross proceeds of about $156,780. Under Rule 144, the filer certifies that no non-public material adverse information is known.

• Class of security: Class A common
• Broker: Fidelity Brokerage Services LLC, Smithfield, RI
• Proposed exchange: NASDAQ
• Recent selling cadence: ~11–12 k shares per day during 8-11 July 2025

While the absolute dollar amount is modest, the consecutive insider sales may be monitored by investors as a sentiment indicator.

Positive

• Transparent disclosure via timely Form 144 allows investors to track insider activity.
• Dilution impact is negligible: 11,881 shares equal ~0.03 % of total shares outstanding.

Negative

• Continued insider selling (over 57 k shares within one week) may be interpreted as weak insider conviction.
• Additional market supply of shares could exert minor short-term pressure on RPID’s share price.

Insights

Financial Analyst

TL;DR: Small, routine insider sale; negligible dilution, modest negative sentiment.

The Form 144 registers another 11,881 RPID shares for sale by Robert G. Spignesi, following four sales over the preceding week. Collectively (~57 k shares) the disposals represent only 0.15 % of outstanding shares and stem from RSU vesting, suggesting liquidity management rather than a strategic exit. The dollar value is immaterial and should not affect fundamentals, but continuing insider supply can weigh marginally on market perception until absorbed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tuszik Oliver

(Last) (First) (Middle)

170 WEST TASMAN DRIVE

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CISCO SYSTEMS, INC. [ CSCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Sales

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/10/2025		F		2,109(1)	D	$69.27	161,044	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for payment of tax liability arising as a result of the partial settlement of a restricted stock unit award originally reported by the reporting person in a Form 3 filed with the Commission on May 6, 2025.

Remarks:

	/s/ Oliver Tuszik by Jay Higdon, Attorney-in-Fact	07/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Rapid Micro Biosystems (RPID) shares are being registered for sale?

The filing covers 11,881 Class A shares under Rule 144.

What is the approximate market value of the shares to be sold?

The aggregate value stated is $39,480.56.

When is the proposed sale date for the RPID shares?

The filer lists an approximate sale date of 14 July 2025.

How many shares of Rapid Micro Biosystems are outstanding according to the filing?

The document shows 39,332,172 shares outstanding.

What insider sales occurred during the past three months?

Between 8-11 July 2025, Robert G. Spignesi sold 45,562 shares for gross proceeds of roughly $156,780.

How were the shares being sold originally acquired?

They were acquired through restricted-stock vesting on 11 July 2025 as compensation.